The Wireless Motility Capsule (WMC) market outlook remains highly attractive, driven by rising prevalence of gastrointestinal disorders, advancements in ingestible sensor technology, and growing adoption in diagnostic gastroenterology. Market growth is poised to accelerate through 2030, underpinned by expanding applications in chronic disease management and digital health integration. Competitive intensity is moderate, with established players like Given Imaging (Olympus) and niche innovators vying for market share through R&D investments and strategic partnerships. Innovation landscape trends highlight miniaturization, AI-driven analytics, and real-time data transmission as key differentiators. However, demand-supply imbalances persist due to high manufacturing complexity and limited production capacity, inflating prices and restricting emerging market penetration. While long-term prospects are optimistic, stakeholders must navigate key risk factors such as regulatory scrutiny, reimbursement challenges, and patient safety concerns. Strategic prioritization of cost optimization, global clinical trials, and payer collaboration will be critical for sustainable growth.